ATE438717T1 - Dp-75 kodierende dna und verfahren zu ihrer verwendung - Google Patents

Dp-75 kodierende dna und verfahren zu ihrer verwendung

Info

Publication number
ATE438717T1
ATE438717T1 AT97927980T AT97927980T ATE438717T1 AT E438717 T1 ATE438717 T1 AT E438717T1 AT 97927980 T AT97927980 T AT 97927980T AT 97927980 T AT97927980 T AT 97927980T AT E438717 T1 ATE438717 T1 AT E438717T1
Authority
AT
Austria
Prior art keywords
nucleic acid
fragments
present
acid sequence
coding dna
Prior art date
Application number
AT97927980T
Other languages
English (en)
Inventor
David Duhl
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Application granted granted Critical
Publication of ATE438717T1 publication Critical patent/ATE438717T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97927980T 1996-06-05 1997-06-04 Dp-75 kodierende dna und verfahren zu ihrer verwendung ATE438717T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1918096P 1996-06-05 1996-06-05
PCT/US1997/009715 WO1997046680A1 (en) 1996-06-05 1997-06-04 Dna encoding dp. 75 and a process for its use

Publications (1)

Publication Number Publication Date
ATE438717T1 true ATE438717T1 (de) 2009-08-15

Family

ID=21791849

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97927980T ATE438717T1 (de) 1996-06-05 1997-06-04 Dp-75 kodierende dna und verfahren zu ihrer verwendung

Country Status (8)

Country Link
US (1) US6300484B1 (de)
EP (1) EP0938553B1 (de)
JP (4) JP2000513571A (de)
AT (1) ATE438717T1 (de)
AU (1) AU3230797A (de)
DE (1) DE69739524D1 (de)
ES (1) ES2331441T3 (de)
WO (1) WO1997046680A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7329741B2 (en) 1996-06-05 2008-02-12 Chiron Corporation Polynucleotides that hybridize to DP-75 and their use
WO1997046680A1 (en) 1996-06-05 1997-12-11 Chiron Corporation Dna encoding dp. 75 and a process for its use
EP1144448A3 (de) * 1999-01-06 2002-03-06 Chiron Corporation Tiam2 (t-zell-lymphom invasion und metastase 2 ) nukleotideaustauschfaktor
US20020165145A1 (en) * 2000-09-25 2002-11-07 Meyers Rachel E. 33521, a novel human guanine nucleotide exchange family member and uses thereof
WO2012019168A2 (en) 2010-08-06 2012-02-09 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
EP2625189B1 (de) 2010-10-01 2018-06-27 ModernaTX, Inc. Manipulierte nukleinsäuren und anwendungsverfahren dafür
AU2012236099A1 (en) 2011-03-31 2013-10-03 Moderna Therapeutics, Inc. Delivery and formulation of engineered nucleic acids
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
DE19216461T1 (de) 2011-10-03 2021-10-07 Modernatx, Inc. Modifizierte nukleoside, nukleotide und nukleinsäuren und verwendungen davon
CA3018046A1 (en) 2011-12-16 2013-06-20 Moderna Therapeutics, Inc. Modified nucleoside, nucleotide, and nucleic acid compositions
WO2013151665A2 (en) 2012-04-02 2013-10-10 modeRNA Therapeutics Modified polynucleotides for the production of proteins associated with human disease
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US9254311B2 (en) 2012-04-02 2016-02-09 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins
PL2922554T3 (pl) 2012-11-26 2022-06-20 Modernatx, Inc. Na zmodyfikowany na końcach
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
WO2015048744A2 (en) 2013-09-30 2015-04-02 Moderna Therapeutics, Inc. Polynucleotides encoding immune modulating polypeptides
EP3052521A1 (de) 2013-10-03 2016-08-10 Moderna Therapeutics, Inc. Polynukleotide zur codierung von low-density-lipoprotein-rezeptor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE151467T1 (de) 1987-11-30 1997-04-15 Univ Iowa Res Found Durch modifikationen an der 3'-terminalen phosphodiesterbindung stabilisierte dna moleküle, ihre verwendung als nukleinsäuresonden sowie als therapeutische mittel zur hemmung der expression spezifischer zielgene
DK0548165T3 (da) 1990-09-13 2001-07-16 Univ Duke Ekspression af G-proteinkoblede receptorer i gær
US5422265A (en) * 1990-12-07 1995-06-06 State Of Oregon, Acting By And Through The State Board Of Higher Education On Behalf Of The Oregon Health Sciences University DNA sequence for the human dopamine receptor D4 and expression thereof in mammalian cells
WO1997046680A1 (en) 1996-06-05 1997-12-11 Chiron Corporation Dna encoding dp. 75 and a process for its use
US8174620B2 (en) 2007-11-06 2012-05-08 Microsoft Corporation High definition media content processing

Also Published As

Publication number Publication date
EP0938553B1 (de) 2009-08-05
EP0938553A1 (de) 1999-09-01
JP2011172588A (ja) 2011-09-08
JP2007289186A (ja) 2007-11-08
AU3230797A (en) 1998-01-05
JP2000513571A (ja) 2000-10-17
DE69739524D1 (de) 2009-09-17
US6300484B1 (en) 2001-10-09
ES2331441T3 (es) 2010-01-04
JP2010017191A (ja) 2010-01-28
WO1997046680A1 (en) 1997-12-11

Similar Documents

Publication Publication Date Title
ATE438717T1 (de) Dp-75 kodierende dna und verfahren zu ihrer verwendung
DE68927456D1 (de) RNS-Katalysator zur Spaltung von spezifischen RNS-Sequenzen
ATE310090T1 (de) Gereinigte coprinus laccasen und nukleinsäuren welche dafür kodieren
RO117190B1 (ro) Construct de acid nucleic şi metodă pentru identificarea expresiei unei gene heteroloage, într-o plantă
HU9603477D0 (en) Synthetic leader peptide sequences
DE69828193D1 (de) Hyaluronan synthase gen und seine verwendung
AU7891498A (en) Flower organ-specific gene and its promoter sequence
NO177570B (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
WO1998011232A3 (en) Human nm23-like protein
DK0602237T3 (da) N-acetylglucosaminyltransferase V-kodende sekvenser
ATE280232T1 (de) Nukleotidsequenzen, welche für das dapf-gen kodieren
KR830003576A (ko) 인간의 프로인슐린선구물질과 프로인슐린 유전자를 분리, 정제하고 미생물에게 전달해서 복제하는 방법
ES2124694T3 (es) Clonacion de la n-metil-hidantoinasa.
ATE221121T1 (de) Verwendung einer dna sequenz, kodierende für ein protein mit der fäligkeit oxalsäure abzubauen, zur genselektion
RU99128056A (ru) Сосудистый белок-1 адгезии, обладающий аминоксидазной активностью
DE69321720D1 (de) Für den interleukin-9-rezeptor kodierende nukleinsäuresequenzen bzw. dafür komplementäre nuleinsäuresequenzen
ATE274061T1 (de) Nukleotid sequenzen kodierend für das lysr2 gen
HUP0001969A2 (hu) Az NNT-1 neurotróf faktor
SE9801098D0 (sv) Receptors
UA87470C2 (ru) Выделенная нуклеиновая кислота, кодирующая рецептор ctla-4 кошки, и вакцина для модулирования иммунного ответа у кошки
WO2000040607A3 (en) Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor
YU29801A (sh) Gen prv-1 i njegova primena
ATE339499T1 (de) Gene welche für proteine, die befähigt sind luziferin zu regenerieren, kodieren, rekombinante dna und verfahren zur herstellung von proteinen, die befähigt sind luziferin zu regenerieren
WO1997017437A3 (en) A chromosome 21 - derived nucleic acid encoding a novel protein, compositions and method using same
CA2261964A1 (en) New tumor suppressor gene and the protein coded thereby, methods of production and use thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties